Evidence map›Paper›PMID 38607278›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Integrin αvβ3 Limits Cytokine Production by Plasmacytoid Dendritic Cells and Restricts TLR-Driven Autoimmunity.

Alina K Lorant, Anna E Yoshida, Emily A Gilbertson, Talyn Chu, Caroline Stefani, Mridu Acharya, Jessica A Hamerman, Adam Lacy-Hulbert

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Alina K LorantBenaroya Research Institute at Virginia Mason, Seattle, WA.
Anna E YoshidaBenaroya Research Institute at Virginia Mason, Seattle, WA.ORCID 0009-0001-3717-1992
Emily A GilbertsonBenaroya Research Institute at Virginia Mason, Seattle, WA.
Talyn ChuBenaroya Research Institute at Virginia Mason, Seattle, WA.
Caroline StefaniBenaroya Research Institute at Virginia Mason, Seattle, WA.ORCID 0000-0003-3420-432X
Mridu AcharyaSeattle Children's Research Institute, Seattle, WA.
Jessica A HamermanBenaroya Research Institute at Virginia Mason, Seattle, WA.ORCID 0000-0001-5864-5299
Adam Lacy-HulbertBenaroya Research Institute at Virginia Mason, Seattle, WA.ORCID 0000-0003-2162-0156
Virginia Mason Medical Center · US

Funding

BCAP regulation of TLR7/9 signaling in LupusR01AI150178 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI HAMERMAN, JESSICA A · 2020 to 2024
$3.7M
Basic Training at the Intersection of Innate and Adaptive Immunity in DiseaseT32AI106677 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL, GOVERMAN, JOAN M · 2013 to 2022
$2.1M
alpha v integrin regulation of B cell toleranceR56AI148785 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI LACY-HULBERT, ADAM · 2021 to 2021
$200k
HHS | National Institutes of Health (NIH) 4T32AI106677-05HHS | National Institutes of Health (NIH) R56AI148785NIAID NIH HHS R01 AI150178NIAID NIH HHS R56 AI148785NIAID NIH HHS T32 AI106677
6 · The paper itself

Abstract

Plasmacytoid dendritic cells (pDCs) are strongly implicated as a major source of IFN-I in systemic lupus erythematosus (SLE), triggered through TLR-mediated recognition of nucleic acids released from dying cells. However, relatively little is known about how TLR signaling and IFN-I production are regulated in pDCs. In this article, we describe a role for integrin αvβ3 in regulating TLR responses and IFN-I production by pDCs in mouse models. We show that αv and β3-knockout pDCs produce more IFN-I and inflammatory cytokines than controls when stimulated through TLR7 and TLR9 in vitro and in vivo. Increased cytokine production was associated with delayed acidification of endosomes containing TLR ligands, reduced LC3 conjugation, and increased TLR signaling. This dysregulated TLR signaling results in activation of B cells and promotes germinal center (GC) B cell and plasma cell expansion. Furthermore, in a mouse model of TLR7-driven lupus-like disease, deletion of αvβ3 from pDCs causes accelerated autoantibody production and pathology. We therefore identify a pDC-intrinsic role for αvβ3 in regulating TLR signaling and preventing activation of autoreactive B cells. Because αvβ3 serves as a receptor for apoptotic cells and cell debris, we hypothesize that this regulatory mechanism provides important contextual cues to pDCs and functions to limit responses to self-derived nucleic acids.

Indexed as

AutoimmunityDendritic CellsIntegrin alphaVbeta3Lupus Erythematosus, SystemicMice, KnockoutSignal TransductionToll-Like Receptor 7AnimalsAutoantibodiesB-LymphocytesCytokinesDisease Models, AnimalLymphocyte ActivationMembrane GlycoproteinsMiceMice, Inbred C57BLAutoantibodiesCytokinesIntegrin alphaVbeta3Membrane GlycoproteinsTlr7 protein, mouseTlr9 protein, mouseToll-Like Receptor 7Toll-Like Receptor 9

Identifiers

PMID38607278
PMCPMC11105983
OpenAlexW4394750134

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.